Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2019 11:42 ET | Source: Reports and Data

Amoxicillin Market To Reach USD 4,962.6 Million By 2026 | Reports And Data

New York, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Government initiatives for the reach of amoxicillin for treating children with bacterial pneumonia, collaborations for technical advancements, and...
January 08, 2019 14:00 ET | Source: American Academy of Dermatology

How to Prevent Common Skin Infections at the Gym; American Academy of Dermatology

ROSEMONT, Ill., Jan. 08, 2019 (GLOBE NEWSWIRE) -- As more people flock to the gym for their New Year’s resolutions, dermatologists from the American Academy of Dermatology are offering words of...
March 02, 2017 08:00 ET | Source: Melinta Therapeutics

Melinta Therapeutics and Menarini Group Enter into Commercial and Co-Development Agreement for Delafloxacin in 68 Countries

NEW HAVEN, Conn. and FLORENCE, Italy, March 02, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, and...
June 14, 2016 12:30 ET | Source: Melinta Therapeutics

Melinta Therapeutics Presenting Results from Baxdela and ESKAPE Programs at ASM Microbe 2016 Meeting

NEW HAVEN, Conn, June 14, 2016 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, announced that...
May 12, 2016 08:00 ET | Source: Melinta Therapeutics

Melinta Therapeutics’ Baxdela™ Successfully Achieves Endpoints in Confirmatory Phase 3 Study in Patients with Hospital-Treated Skin Infections

New Haven, CT, May 12, 2016 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, today announced top-line results...
January 05, 2016 08:00 ET | Source: Melinta Therapeutics

Melinta Therapeutics to Present at 34th Annual J.P. Morgan Healthcare Conference

New Haven, CT, Jan. 05, 2016 (GLOBE NEWSWIRE) -- Melinta Therapeutics today announced that Dr. Eugene Sun, the Company’s interim Chief Executive Officer, will be providing a corporate update at...
May 19, 2015 16:00 ET | Source: Melinta Therapeutics

Melinta Therapeutics Study Demonstrates Significant Burden of Obesity on Patients' Recovery from Acute Bacterial Skin Infections

New Haven, CT, May 19, 2015 (GLOBE NEWSWIRE) -- Melinta Therapeutics today presented data that show the negative impact of obesity on patients' recovery from acute bacterial skin and skin structure...